Maxim Group analyst Jason McCarthy downgraded Panbella Therapeutics (NASDAQ: PBLA) from Buy to Hold. The analyst commented:"On 9/30/22, Panbela announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE